Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Evolving Standards: Good Clinical Practice Insights from US FDA, MHRA UK, and Health Canada.
Journal: Clinical pharmacology and therapeutics
Published: August 28, 2025
FDA Approval Summary: Pemigatinib for Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with FGFR2 Fusion or Other Rearrangement.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 28, 2022
Nelarabine, etoposide, and cyclophosphamide in relapsed pediatric T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma (study T2008-002 NECTAR).
Journal: Pediatric blood & cancer
Published: February 26, 2022
FDA Approval Summary: Pembrolizumab for the First-line Treatment of Patients with MSI-H/dMMR Advanced Unresectable or Metastatic Colorectal Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 10, 2021
FDA Approval Summary: Pembrolizumab for the Treatment of Tumor Mutational Burden-High Solid Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 27, 2021
FDA Approval Summary: Entrectinib for the Treatment of NTRK gene Fusion Solid Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 21, 2020
A phase I study of panobinostat in children with relapsed and refractory hematologic malignancies.
Journal: Pediatric hematology and oncology
Published: April 28, 2020
FDA Approval Summary: Pembrolizumab for the Treatment of Microsatellite Instability-High Solid Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 12, 2018
Cushing Disease in a patient with Multiple Endocrine Neoplasia type 2B.
Journal: Journal of clinical and translational endocrinology case reports
Published: April 25, 2017
Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas.
Journal: The New England journal of medicine
Published: December 29, 2016
FDA Approval Summary: TAS-102.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 29, 2016
Prolonged Complete Response in a Pediatric Patient With Primary Peripheral T-Cell Lymphoma of the Central Nervous System.
Journal: Pediatric hematology and oncology
Published: September 19, 2015
Last Updated: 09/26/2026